Allianz Asset Management Gmb H Cytosorbents Corp Transaction History

Allianz Asset Management Gmb H

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$3.61 - $5.22 $474,613 - $686,283	-131,472 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$4.33 - $7.63 $859,998 - $1.52 Million	-198,614 Reduced 60.17%	131,472 $661,000
Q2 2019 Aug 08, 2019	SELL	$5.92 - $7.78 $16,481 - $21,659	-2,784 Reduced 0.84%	330,086 $2.18 Million
Q1 2019 May 13, 2019	SELL	$6.82 - $8.56 $25,656 - $32,202	-3,762 Reduced 1.12%	332,870 $2.52 Million
Q4 2018 Feb 14, 2019	SELL	$7.05 - $12.64 $95,499 - $171,221	-13,546 Reduced 3.87%	336,632 $2.72 Million
Q3 2018 Nov 13, 2018	BUY	$10.95 - $14.8 $1.01 Million - $1.37 Million	92,508 Added 35.9%	350,178 $4.52 Million
Q2 2018 Aug 13, 2018	BUY	$6.9 - $12.35 $1.78 Million - $3.18 Million	257,670 New	257,670 $2.94 Million

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.